Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study

Yoshitomo Kushima^1,2Yasuo Shimizu^1*Ryo Arai¹Kazuyuki Chibana¹Yuka Shimizu^1,3Masahiro Amagai³Akihiro Takemasa¹Naoya Ikeda¹Meitetsu Masawa¹Atsushi Kushima²Hiroaki Okutomi¹Yusuke Nakamura¹Rinna Tei¹Yuki Ando¹Nana Yazawa¹Yuto Goto¹Yasuo Haruyama¹Tatsuo Yukawa⁴Seiji Niho¹

• ¹Dokkyo Medicacal University, Mibu, Japan
• ²Kushima Internal Medicine Clinic, Moka, Japan
• ³Amagai Internal Medicine Clinic, Mibu, Japan
• ⁴Yukawa Clinic of Internal Medicine, Utsunomiya, Japan

Frontiers Corrigendum Template for Authors A corrigendum refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers Editorial approval. Instructions: ● please read through all the templates before choosing ● pick the most relevant text template(s) from the following page and delete all others. ● edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ● please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ● submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Corrigendum: Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study. Text Correction In the published article, there was an error. [Incorrect description of statistical methods]. A correction has been made to [1.4 Statistical analysis], [Paragraph Number 2]. This sentence previously stated: "[Changes over time between groups were evaluated by repeated measures, and comparisons of the parameters between the baseline and each time point were evaluated using the Bonferroni method.]" The corrected sentence appears below: "[Changes over time between groups were evaluated by repeated measures, and comparisons of the parameters between the baseline and each time point were evaluated using the Least significant difference (LSD) method.]" Error in Figure/Table Legend In the published article, there was an error in the legend for [FIGURE 2] as published. [Incorrect description of statistical methods]. The corrected legend appears below. [The bars represent the 95% CI, p-values are for repeated measurements within a group, and the Least significant difference (LSD) method was used for time comparisons.] Error in Figure/Table In the published article, there was an error in [FIGURE 3C] as published. [Incorrect description of ratio for patients in Pie Chart]. The corrected [10% ➪48%] .No changes to the captions are necessary. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges. Kushima Y, Shimizu Y, Arai R, Chibana K, Shimizu Y, Amagai M, Takemasa A, Ikeda N, Masawa M, Kushima A, Okutomi H, Nakamura Y, Tei R, Ando Y, Yazawa N, Goto Y, Haruyama Y, Yukawa T, Niho S (2025) Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study. Front Allergy. 2025 Mar 17;6:1537501.